Maintenance (month 7+): Stable side-effect profile broadly similar to retatrutide alone, with cagrilintide adding amylin-pathway effects
or to electronic claim form ASC 837P in Loop 2400, Segment SV101-2, with the Qualifier "HC" entered to Segment SV101-1, unless otherwise directed by the payer
The Centers for Medicare & Medicaid Services (CMS) recently said that broader access to GLP-1 drugs for weight loss could begin in Medicaid as early as May and in Medicare Part D in January 2027, under its BALANCE Model
However, it remains under investigation whether these benefits are directly due to the GLP-1 agonists or a result of the weight loss they facilitate
The general shape that registered dietitians and GLP-1-focused nutrition guides consistently recommend is: Lead every small meal with protein
Patients joining the Semaglutide Seattle program begin with an in-office consultation and body composition analysis on our SECA Scale (the gold standard for medical body comp analysis)